标题
Fenofibrate and the kidney: an overview
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 43, Issue 5, Pages 522-531
出版商
Wiley
发表日期
2013-02-19
DOI
10.1111/eci.12068
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- New Fibrate Use and Acute Renal Outcomes in Elderly Adults
- (2013) Ying Y. Zhao ANNALS OF INTERNAL MEDICINE
- Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline
- (2012) Yelena Slinin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination
- (2012) Theodosios D. Filippatos CARDIOVASCULAR DRUGS AND THERAPY
- Lipid Nephrotoxicity: New Concept for an Old Disease
- (2012) Leonard Gyebi et al. CURRENT HYPERTENSION REPORTS
- Therapeutic options for statin-intolerant patients
- (2012) Michael S. Kostapanos et al. CURRENT MEDICAL RESEARCH AND OPINION
- Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]
- (2012) Michael S. Kostapanos et al. Current Vascular Pharmacology
- Reversibility of Fenofibrate Therapy-Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants
- (2012) J. C. Mychaleckyj et al. DIABETES CARE
- Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
- (2012) D. E. Bonds et al. DIABETOLOGIA
- Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy
- (2012) Supriya Kadian et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status
- (2012) Agnieszka Makówka et al. Lipids in Health and Disease
- The combined strategy with PPARα agonism and AT1 receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat
- (2012) Harish Kumar Bishnoi et al. PHARMACOLOGICAL RESEARCH
- Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?
- (2012) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C
- (2012) V. Ncube et al. ANNALS OF CLINICAL BIOCHEMISTRY
- US Renal Data System 2011 Annual Data Report
- (2011) Allan J. Collins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Role of Statins in Chronic Kidney Disease
- (2011) Rigas G. Kalaitzidis et al. AMERICAN JOURNAL OF NEPHROLOGY
- “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study
- (2011) R.-D. Ting et al. DIABETES CARE
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity
- (2011) Rebecca L. Attridge et al. Journal of Clinical Lipidology
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Peroxisome Proliferator-Activated Receptor-αActivation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension
- (2011) Dexter L. Lee et al. PPAR Research
- PPARα agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity
- (2010) Xiaoyang Hou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
- (2010) T. M. E. Davis et al. DIABETOLOGIA
- Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy
- (2010) Lingyun Li et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice
- (2010) Deepa Taneja et al. JOURNAL OF LIPID RESEARCH
- Peroxisome Proliferator-Activated Receptor Agonism Prevents Renal Damage and the Oxidative Stress and Inflammatory Processes Affecting the Brains of Stroke-Prone Rats
- (2010) P. Gelosa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- PPARα: an emerging therapeutic target in diabetic microvascular damage
- (2010) Anne Hiukka et al. Nature Reviews Endocrinology
- Role of triglyceride-rich lipoproteins in diabetic nephropathy
- (2010) John C. Rutledge et al. Nature Reviews Nephrology
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy
- (2009) C. Forsblom et al. DIABETES CARE
- Peroxisome proliferator-activated receptor-α activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats
- (2009) Seok Joon Shin et al. HYPERTENSION RESEARCH
- Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism
- (2009) Pitchai Balakumar et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People
- (2008) Jean-Claude Ansquer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- PPAR-Alpha Agonist Fenofibrate Induces Renal CYP Enzymes and Reduces Blood Pressure and Glomerular Hypertrophy in Zucker Diabetic Fatty Rats
- (2008) Xueying Zhao et al. AMERICAN JOURNAL OF NEPHROLOGY
- Hypertensive nephrosclerosis
- (2008) Gary S Hill CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity
- (2008) M. Elisaf et al. CURRENT PHARMACEUTICAL DESIGN
- Improvement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats
- (2008) L. Chen et al. INFLAMMATION RESEARCH
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- The pathogenesis of diabetic nephropathy
- (2008) Suma Dronavalli et al. Nature clinical practice. Endocrinology & metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search